Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADAM17 | P78536 | 18/20 | 0.71 |
| ▸ | ADAMTS4 | O75173 | 3/20 | 0.69 |
| ▸ | MMP3 | P08254 | 3/20 | 0.69 |
| ▸ | ADAMTS1 | Q9UHI8 | 3/20 | 0.69 |
| ▸ | ADAMTS5 | Q9UNA0 | 3/20 | 0.69 |
| ▸ | MMP7 | P09237 | 2/20 | 0.69 |
| ▸ | MMP8 | P22894 | 2/20 | 0.69 |
| ▸ | MMP13 | P45452 | 1/20 | 0.65 |
| ▸ | MMP10 | P09238 | 1/20 | 0.63 |
| ▸ | MMP14 | P50281 | 1/20 | 0.63 |
| ▸ | MMP15 | P51511 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6597057 | 0.92 | ADAM17 (0.84) | ADAM17ADAMTS4MMP3ADAMTS1ADAMTS5 | |
| SCHEMBL7399907 | 0.90 | ADAM17 (0.85) | ADAM17ADAMTS4MMP3ADAMTS1ADAMTS5 | |
| SCHEMBL7403312 | 0.88 | ADAM17 (0.85) | ADAM17ADAMTS4MMP3ADAMTS1ADAMTS5 | |
| SCHEMBL7404838 | 0.87 | ADAM17 (0.67) | ADAM17ADAMTS4MMP3ADAMTS1ADAMTS5 | |
| SCHEMBL7405011 | 0.87 | ADAM17 (0.74) | ADAM17ADAMTS4MMP3ADAMTS1ADAMTS5 | |
| SCHEMBL7404844 | 0.87 | ADAM17 (0.67) | ADAM17ADAMTS4MMP3ADAMTS1ADAMTS5 | |
| SCHEMBL7399763 | 0.87 | ADAM17 (0.77) | ADAM17ADAMTS4MMP3ADAMTS1ADAMTS5 | |
| SCHEMBL7398356 | 0.87 | ADAM17 (0.67) | ADAM17ADAMTS4MMP3ADAMTS1ADAMTS5 | |
| SCHEMBL7401788 | 0.87 | ADAM17 (0.71) | ADAM17ADAMTS4MMP3ADAMTS1ADAMTS5 | |
| SCHEMBL7406766 | 0.87 | ADAM17 (0.86) | ADAM17ADAMTS4MMP3ADAMTS1ADAMTS5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1263756-A2 | BETA-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-ALPHA | Bristol-Myers Squibb Pharma Company (US) | 2002-12-11 | — | — | EP | claimed |
| WO-2001070734-A2 | BETA-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-ALPHA | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2001-09-27 | — | — | WO | claimed |
| EP-1263756-A2 | BETA-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-ALPHA | Bristol-Myers Squibb Pharma Company (US) | 2002-12-11 | — | — | EP | disclosed |
| WO-2001070734-A2 | BETA-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-ALPHA | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2001-09-27 | — | — | WO | disclosed |